Replies to post #8795 on Revance Therapeutics Inc (RVNC)

[alertmeipp]

Q3 this year was especially weak re: discretionary spending because of the election.

Agree, money is tight, they will need a raise, do a partnership or asset sale PLUS massive cost cut soon if this deal failed.

[Tomdontworry]

Every public company is audited by reputable firms and every single decision is ran by the auditors/advisors. Revence didn’t choose to disclose “going concern issue.” They were “advised” because the financial picture dramatically changed and based on forecasts/projections management doesn’t believe they can grow the business enough to sustain operating expenses and loan commitments. It may be too late to save Foley’s disastrous decisions if Crown backs out. Be very very careful here.